Format

Send to

Choose Destination
Curr Stem Cell Res Ther. 2019 Nov 6. doi: 10.2174/1574888X14666191107103755. [Epub ahead of print]

Phospholipase Cγ signaling in bone marrow stem cell and relevant natural compounds therapy.

Author information

1
Department of Spine Surgery, Honghui Hospital Affiliated to Xi'an Jiaotong University, Xi'an, China.
2
Department of orthopedics, Fifth Hospital of Xi'an, Xi'an, China.
3
Department of neurosurgery, Shunde Hospital of Southern Medical University, Fo Shan, China.

Abstract

Excessive bone resorption has been recognized as a major role in the development of bone-related diseases such as osteoporosis, rheumatoid arthritis, Paget's disease of bone, and cancer metastasis to bone. Phospholipase Cγ (PLCγ) family members PLCγ1 and PLCγ2 are critical regulators of signaling pathways downstream of growth factor receptors, integrins, and immune complexes and play a crucial role in the osteoclastogenesis. Ca2+ signaling has been recognized as an essential pathway to the differentiation of osteoclasts. With growing attention and research about natural occurring compounds, the therapeutic use of natural active plant-derived products has been widely recognized in recent years. In this review, we summarized the recent research on PLCγ signaling in bone marrow stem cells and the use of several natural compounds that were proven to inhibit RANKL-mediated osteoclastogenesis via modulating PLCγ signaling pathways.

KEYWORDS:

Calcium signaling; Natural occurring compounds; Osteoclast; Phospholipase Cgamma signaling; bone marrow stem cell; natural compounds therapy

Supplemental Content

Full text links

Icon for Bentham Science Publishers Ltd.
Loading ...
Support Center